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Abstract 
 
Research is focused on CpG islands and on the mechanism that poly(ADP-ribosyl)ation uses 
to defend the unmethylated state of these important DNA sequences which are located in the 
promoter regions of the housekeeping genes having a role of transcription regulators. 
Data here reported show that inhibition of PARP activity allows the diffuse insertion of 
methyl groups onto some CpG islands and in particular on the CpG island which is located in 
the promoter region of Dnmt1 gene. Hence, following inhibition of PARPs activity, this 
promoter loses its protection against methylation becoming silenced through methylation as 
shown by analyses with Methylation Sensitive PCR (MS-PCR) and sequencing after 
bisulphite treatment. 
Analyses of Western Blotting, RT-PCR and Real-time RT-PCR confirm that the gene has 
undergone silencing. The role of ADP-ribose polymers in silencing Dnmt1 has been 
demonstrated by additional experiments in which overexpression of poly(ADP-ribose) 
glycohydrolase leads to reduction of ADP-ribose polymers in nuclei associated to a sharp 
decrease of Dnmt1 level respect to control. A parallel genome-wide methyl-sensitive 
restriction assay demonstrates that the variation of Dnmt1 level is followed by a bimodal 
alteration of DNA methylation pattern. In fact, the inhibition of poly(ADP-ribosyl)ation 
initially causes an increase in methyl-group insertion onto DNA while this phenomenon is 
reversed after prolonged treatments and demethylation is detected within Alu sequences. 
Considering the important role played by Dnmt1 in the epigenetic scenario, these data lead 
us to think about what happens in tumor cells where both anomalous methylation of some 
CpG islands and diffuse hypomethylation are present. These findings open up a new path into 
epigenetic research in tumors. What is remarkable is that the demethylated pattern found in 
Alu sequences after treatment of cells with 3-ABA for 96 hours is very similar to the one 
found on DNA from cells treated with 5-AZA for the same time. The discovery of a DNA 
demethylating activity dependent on the use of inhibitors of poly(ADP-ribosyl)ation process 
increases the knowledge of mechanism by which these inhibitors enhance the cytotoxicity of 
other anticancer agents. 
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Introduction 
 
The DNA methylation machinery 
 
DNA methylation (for reviews see Costello and Plass, 2001; Bird, 2002; Zlatanova et al., 
2004; Caiafa and Zampieri, 2005) is the post-synthetic modification that by transferring a 
methyl group from S-adenosylmetionine to carbon-5 of cytosine ring introduces 5mC as new 
base on DNA. Enzymes involved in this reaction are DNA methyltransferases and their 
preferential target for methylation are cytosines located in CpG dinucleotides. The mCpG 
dinucleotides are distributed in a non-random fashion in genomic DNA so that methylation 
pattern is characterized by the presence of methylated cytosines on the bulk of DNA while the 
unmethylated ones are mainly located within particular regions termed CpG islands. Specific 
DNA methylation pattern results from the combination of maintenance and de novo 
methylation and demethylation processes. Maintenance methylation, which occurs within a 
minute or two after replication, recognizes and modifies hemimethylated sites generated 
during DNA replication thus preserving the tissue-specific methylation pattern. DNA 
methyltransferase 1 (Dnmt1) is considered primarily responsible for maintenance methylation 
due to its preference for hemimethylated DNA, its maximum level of expression being in S 
cell-cycle phase (Szyf et al.,1991) and not least because of its association with proliferating 
cell nuclear antigen (PCNA) during DNA replication at DNA replication foci (Chuang et al., 
1997). Dnmt3a and Dnmt3b are considered responsible for the de novo methylation process 
which explains how the pattern of methylation can be changed by introducing new methyl 
groups onto DNA at sites in which neither strand was previously methylated. These enzymes 
play an important role during early stages of embryonic development when a bimodal pattern 
of methylation is defined (Kafri et al., 1992). It is important to say that it is too simplistic to 
consider that only these enzymes are involved in DNA methylation as for most of them there 
are several isoforms and new Dnmts have been identified (for review see Robertson, 2002). A 
great deal of research is being carried out to establish their roles. The original distribution of 
roles mentioned above for the main Dnmts may have to be reconsidered in light of the fact 
that some of them have been seen cooperating in maintaining DNA methylation and gene 
silencing in human cancer cells during DNA replication (for review see El-Osta, 2003).  
The thermodynamic problem, concerning the removal of methyl groups from cytosine 
makes the understanding of DNA demethylation mechanism somewhat complicated. A DNA 
demethylase activity, capable of catalyzing replacement of the methyl group with a hydrogen 
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derived from water and of releasing the methyl group in the form of methanol, has been 
proposed as well as the alternative possibility of the removal of 5mC or 5mCpG dinucleotide 
by glycosylase activity and their substitution with the unmethylated base or dinucleotide. 
Whatever the enzymatic mechanism(s) may be, DNA demethylation is an active process in 
cells and plays a role not only in the definition of the methylation pattern in early stages of 
development but also in the passage towards pathological events as tumorigenesis (for 
reviews see Cedar and Verdine, 1999; Bird, 2003).  
Histone modifications, DNA methylation and proteins able to bind methylated DNA play a 
dynamic role in determining chromatin structure suitable for gene expression or silencing. At 
present, much information is available as to how several epigenetic modifications work 
together in determining regions of chromatin that have to be more or less suitable for 
transcription (for review see Jaenisch and Bird, 2003). An unresolved problem is the timing 
with which the various epigenetic events occur in establishing gene expression. On this 
subject at least two scenarios can be suggested. One foresees DNA methylation as the first 
event as it was observed that histone deacetylase can reach chromatin through its association 
with proteins able to recognize and bind methylated DNA (Nan et al., 1998; Jones et al., 
1998). The second scenario considers DNA methylation to be the final stabilizing moment 
which occurs only after epigenetic events associated with histones (i.e. K9H3 methylation) 
have already shut down gene expression (for review see Bird, 2001). 
There is also considerable evidence that chromatin dynamics involve the action of small 
RNAs (siRNAs and miRNAs) in all eucaryotes including mammals (for review see Lippman 
and Martienssen, 2006). Using human tissue culture cells, it has been shown that promoter-
directed siRNA inhibits transcription of an integrated, proviral elongation factor 1alpha 
(EF1A) promoter–green fluorescent protein reporter gene and of endogenous EF1A by DNA 
methylation–mediated silencing (Morris et al., 2004). Similar results were obtained with 
siRNA targeted to E-Cad and erB2/HER2 promoters colocalizing with CpG islands 
(Kawasaky and Taira, 2004). 
 
Distribution of mCpG and CpG dinucleotides on genomic DNA 
 
The frequence with which CpG dinucleotides are found on genome is much lower than 
expected except for CpG island regions where their number is nearer to the expected one. 
This happened during evolution due to the presence of spontaneous deaminase activity in 
nuclei (for review see Jones and Baylin, 2002). This enzymatic reaction transforms 
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methylated cytosine into thymine while the unmethylated cytosine is transformed into uracil. 
Subsequent control and repair mechanisms recognize uracil as an extraneous base on DNA 
and thus substitute it while this substitution does not happen where thymine is concerned as it 
is a common base on DNA. 
Going back to CpG islands being enriched in CpG dinucleotides, the explanation lies in the 
non methylation of their normal state which preserves their regions from deamination-
dependent mutations. 
Summarizing some characteristics of CpG islands (Antequera and Bird, 1993; Antequera 
and Bird, 1994; Antequera, 2003) there are about 30,000 generally located in the 5’ promoter 
region of housekeeping genes sometimes overlapping the coding region to variable extents 
(usually the first exon). Although their sequence is enriched in CpG dinucleotides, which are 
the best substrates for DNA methyltransferase, the CpG islands are unmethylated. There is 
evidence that the transcription of genes associated with them is active when these regions are 
in unmethylated state while it is inhibited when these regions undergo methylation (for 
reviews see Jones and Baylin, 2002; Robertson, 2002) (Fig. 1).. It is to note that CpG islands 
have recently been found in several tissue-specific and imprinted genes within the genes 
themselves without their methylation blocking gene expression (for review see Jones, 1999).  
Along DNA other discrete regions, enriched in CpG dinucleotides, must be considered. They 
are repetitive elements termed B elements (for review see Turker, 2002) in mice and Alu 
elements in humans (Takai and Jones, 2002). Analysis of sequence of human chromosomes 
21 and 22 has led to the definition of more stringent parameters which allow the 
distinguishing of CpG islands and Alu sequences (Takai and Jones, 2002). The new 
parameters for definition of CpG islands are fixed in this way: minimum size ³ 0.5 kbp, C+G 
content ³ 55% and observed CpG/expected CpG ³ 0.65. The important difference between 
CpG islands and Alu repeats  lies in the fact that the latter are a good substrate for the DNA 
methylation that occurs in these regions that are generally methylated. B and Alu sequences 
are defined cis-acting methylation centers both as suspected of signalling de novo DNA 
methylation and as - in absence of a boundary - they may be able to spread methylation to the 
adjacent DNA regions.  
A strong association is shown between CpG islands and Alu repeats. A detailed analysis of 
the sequence of human chromosomes 21 and 22 showed that 54.4 % of CpG islands occur 
between Alu regions and the number of CpGs that are found in 5' regions of genes is about the 
same as the number of Alu-associated CpGs (Takai and Jones, 2002). 
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Fig. 1: Main features of CpG island regions 
 
 
The jigsaw of unmethylated state of CpG islands 
 
Concerning the regulation of DNA methylation process, two unresolved questions are:  
a) to clarify the mechanism by which CpG islands are protected from methylation during 
replication and in chromatin; 
b) to understand how CpG islands, located in the promoter regions of tumor suppressor 
genes, become methylated during tumorigenesis while they are unmethylated in normal cells. 
There has been a lot of research to discover the mechanism that normally keeps CpG 
islands unmethylated, some of which has tried to pinpoint cis-acting sequences able to 
conduct such an important mechanism. As CpG island sequences have been seen to be 
methylatable in in vitro experiments the hypothesis that they are intrinsically unmethylatable 
has fallen through (Bestor et al., 1992).  
 
 
 
 
CpG 
islands 
 
· represent 1-2% of genomic DNA 
 
• are about 30.000  
 
• are generally located in the 5’ promoter 
region of housekeeping genes sometimes 
overlapping the coding region to variable 
extents  
 
• their sequence is enriched in CpG 
dinucleotides 
 
• are unmethylated 
 
• transcription of genes associated with them is 
active when these regions are unmethylated 
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Attention of many researchers has been diverted to consensus binding sites for 
transcription factor Sp1 (Brandeis et al., 1994; Macleod et al., 1994; Mummanemi et al., 
1998). The mouse Aprt housekeeping gene – whose CpG island includes the promoter, the 
first and second exons and the first intron – has been chosen for the study of this mechanism 
as Sp1 consensus sites are present in its promoter region. Their connection to the mechanism 
that keeps the CpG islands unmethylated is being researched with interest as these Sp1 sites 
often occupy a strategic position both in the mouse B1 (for review see Turker, 2002) and in 
the human Alu repetitive elements that often flank CpG islands (Takai and Jones, 2002). B1 
and Alu sequences - because of their high methylation level - are considered methylation 
centers and  Sp1 sites in these patterns are seen as boundaries able to stop the spreading of 
methylation from B1 and Alu elements to unmethylated CpG islands (Fig. 2). 
The diffusion of methylation from methylated CpG dinucleotides toward the adjacent 
unmethylated ones has previously been amply shown (for review see Lindsay and Adams, 
1996) but without explaining how CpG islands are protected from the spreading of 
methylation. As concerns the expression of mouse Aprt gene, it has been shown that among 
the Sp1 consensus sites, sites three and four are required for gene transcription while site two 
is the specific one in the blocking of methylation spreading and is reinforced in this role by 
sites three and four (Mummaneni et al., 1998). Their silencing is a gradual process in 
differentiated cells (Yates et al., 2003). If it is the boundary caused by Sp1 which isolates the 
islands from a general state of methylation it can be presumed that in tumorigenesis this 
mechanism is, in some way, lost (Fig. 2). 
However, data in literature are not unanimous as while some experiments show that the 
gene-correlated CpG island is methylated when Sp1 binding sites, in correspondence with 
gene, are disrupted by direct mutagenesis (Brandeis et al.,1994; Macleod et al., 1994; 
Mummanemi et al., 1998), no anomalous methylation of CpG islands is found in mice in 
which Sp1 is not expressed following homozygous deletion (Marin et al,. 1997). Anyway this 
mechanism cannot be considered universal as Sp1 consensus sites are not always present in 
promoter regions of housekeeping genes. It is reasonable to think that some other 
transcription factor(s), through their ties with active promoters containing CpG islands, can 
act as trans-acting elements able to protect the unmethylated state of these DNA regions. 
Experiments, carried out on T24 bladder carcinoma cell line, in which the remethylation 
kinetics was examined for p16 gene after it had been demethylated by treatment with 5-aza 
2’-deoxycytidine, have shown that the timing of remethylation varied, being longer for 
promoter region than for coding regions of gene, i.e. exon 2. This could be due to the presence  
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Fig. 2: Alu repeats and CpG islands are physically and functionally correlated on 
genomic DNA: a role for Sp1 elements. In the scheme CpG island is juxtaposed to multiple Alu 
elements which have been proposed as “de novo methylation centers”. Sp1 sites, located upstream and 
downstream of transcription start in the island, play a role in preventing methylation. Cluster of Sp1 elements is 
suggested as boundary region capable of protecting CpG island from the spreading of methylation arising from 
Alu elements. Grey and red lollipops represent non-methylated and methylated CpGs, respectively (Adapted 
from Caiafa and Zampieri, 2005). 
 
 
of transcription factor(s) on promoter region capable of impeding Dnmt1 from entering DNA 
(Bender et al., 1999).  
An important point in determining variation of methylation patterns is the nuclear level of 
Dnmt1 as it has often been seen to be high in tumor cells (Baylin et al., 2001). Thus 
anomalous increased level of the enzyme could be involved in determining aberrant 
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introduction of new methyl groups onto DNA. Housekeeping gene promoters are 
hypermethylated, with the silencing of correlated genes, in human cell lines expressing 50-
fold increased level of Dnmt1 (HMT) (Vertino et al., 1996) and further research, performed 
on the same cells, has shown that not all loci containing CpG rich regions are equally affected 
by methylation in cells overexpressing Dnmt1 but about 70% of them were resistant to de 
novo methylation and only a few of them (3,8%) were methylation-prone (Feltus et al., 2003). 
Recently, it has been shown that RNA interference (RNAi)-mediated silencing of Dnmt1 
leads to promoter demethylation and re-expression of some tumor suppressor genes in several 
cancer cells (Robert et al., 2003; Suzuki et al., 2004). This confirms the important role played 
by Dnmt1 in tumorigenesis although additional data have shown that CpG island 
hypermethylation is maintained in human cancer cells after homozygous deletion (Rhee et al., 
2000) or RNAi-mediated depletion of Dnmt1 (Ting et al., 2004).  
As not all tumor cells in which there is hypermethylation of tumor suppressor genes show 
an overexpression of Dnmt1 (Eads et al., 1999), and as the expression of Dnmt1 is cell-cycle 
dependent (Szyf et al., 1991), attention has been diverted to the idea that the expression of 
Dnmt1 can occur in an anomalous cell-cycle phase - i.e. in G1/early S phase - when CpG rich 
regions and active genes replicate (Delgado et al., 1998). It has been observed that 
remethylation process can also occur in cells blocked in G1 (Bender et al., 1999). 
In this scenario the competition existing between p21 and Dnmt1 for the same binding 
domain on PCNA (Chuang et al., 1997) may play an important role. PCNA is the protein to 
which Dnmt1 binds when, immediately following replication, the maintenance methylation 
intervenes to guarantee that methylation pattern of the parent strand is conserved on the newly 
synthesized one. In early S phase, when CpG island regions replicate (Delgado et al., 1998), 
the level of Dnmt1 is too low to compete with p21 for the binding site on PCNA and so 
replication occurs without subsequent methylation. It has been suggested that an as yet 
unidentified biological event, able to induce Dnmt1 expression in early S phase, could make 
the binding to PCNA easier thus allowing the methylation of early replicating genes in 
tumorigenesis (Baylin, 1997). Moreover, Dnmt1 seems to be a cofactor capable of regulating 
negatively expression of p21 through a direct or indirect link with Sp1 (Milutinovic et al., 
2004). Thus, an anomalous overexpression of Dnmt1 in the early S phase could further 
facilitate the formation of PCNA-Dnmt1 complex. 
Another suggested mechanism sees the action of a protein which, linking Dnmt1, inhibits 
its catalytic activity, thus preventing the introduction of new methyl groups onto DNA. This 
role is played by Rb (Pradhan et al., 2002), a protein involved in cell-cycle control and 
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therefore having an important role as tumor suppressor gene.  It has been shown that Rb links 
through its pockets B and C the regulatory domain of Dnmt1 and that following this 
association the bond existing between Dnmt1 and DNA is destabilized. Overexpression of Rb 
leads to DNA hypomethylation. All this suggests that this mechanism plays a role in the 
hypermethylation of oncosuppressor genes in tumors where often Rb is absent or mutated 
(Hanahan and Weinberg, 2000). 
The outcome that ORIs map within or immediately adjacent to CpG islands has been seen 
as a mechanism probably involved in maintaining the unmethylated state of CpG islands. 
Analysis of very short DNA fragments (< 1.5 Kbp), which are formed at the beginning of S 
phase, allowed the observation that their sequence is similar to that of unmethylated CpG 
island regions. Replication time of CpG islands is about 2-2.5 hours while the bulk of DNA 
needs more time to replicate. Thus origins of replication colocalize frequently with CpG 
islands so that the great number of proteic factors involved in these processes could be enough 
to make access difficult to Dnmt1 that, as mentioned above, is less expressed in early S-phase. 
Experiments performed on human X-linked hypoxantine phosphoribosyltransferase gene 
(HPRT) have shown that colocalization of CpG islands and ORIs is dependent on the 
methylation state of CpG island. In fact the CpG island, which is methylated in the inactive 
allele, replicates in late S phase (Schmidt and Migeon, 1990). Thus, unmethylated CpG island 
regions should be particularly suitable for starting DNA replication because of their 
uncondensed chromatin structure (Tazi and Bird, 1990) and this colocalization has been 
suggested as a mechanism by which CpG islands are protected from methylation during 
replication (Antequera and Bird, 1999), (Fig. 3).  
Finally, there are proteins that targeting Dnmts on specific DNA regions mediate 
transcriptional silencing (for Reviews see Robertson, 2002; El-Osta, 2003). 
At present much information is available but not enough to allow the elaboration of a final 
model(s) explaining how CpG islands are protected from methylation.  In spite of the great 
effort put into solving this scientific problem, much still has to be done to provide definite 
proof which solves this fascinating puzzle. 
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Fig. 3: ORIs are often located at CpG island regions in vivo. The fact that ORIs map within or 
immediately adjacent to CpG islands has been seen as a mechanism probably involved in maintaining the 
unmethylated state of CpG islands. CpG islands, because of their localization in decondensed chromatin regions, 
could offer an easier replication starting point than condensed chromatin. Thus CpG islands and correlated active 
genes replicate in early S phase while silent genes in more advanced S phase. The lower level of Dnmt1 in early 
S phase than during the S phase favours the maintaining of the unmethylated state of CpG islands (Adapted from 
Caiafa and Zampieri, 2005). 
 
 
Poly(ADP-ribosyl)ation 
 
Poly(ADP-ribosyl)ation, an enzymatic mechanism catalyzed by a family of ADP-ribose 
polymerases, leads to the transfer of ADP-ribose unit from nicotinamide adenine dinuleotide 
(NAD) to chromatin proteins (D’Amours et al., 1999, Kim et al., 2005). Chains of different 
sizes ranging from 2 to 200 units are built on a protein acceptor and moreover these chains are 
branched and so rich in negative charges that they become molecular adaptors of the protein 
acceptor capable of interfering with the link between protein-protein and protein-DNA. The 
dynamics of poly(ADP-ribosyl)ation process is guaranteed by the presence of many  
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Fig. 4: Poly(ADP-ribosyl)ation reaction and enzymes. Synthesis of linear and branched chains of 
poly(ADP-ribose) by PARP on chromatin protein using NAD as substrate. The action of poly(ADP-ribose) 
glycohydrolase (PARG) is directed to linear and branched ADP-ribose polymers (adapet from Zardo et al., 
2003). 
 
 
poly(ADP-ribose) polymerases and one poly(ADP-ribose) glycohydrolase (PARG), an 
enzyme which hydrolizes and detaches ADP-ribose units from the polymers (Fig. 4). 
A shuttle mechanism has been proposed to explain how PARG, which is a cytoplasmatic 
enzyme, can work in nuclei where most PARPs are located (Davidovic et al.,. 2001). 
Degradation of polymers starts when their nuclear level exceeds 15 mM and their half-life 
is calculated at one minute (Alvarez-Gonzalez and Althaus, 1989). 
Recently it has been recognized that PARPs are a family of enzymes composed of 18 
members (Amé et al., 2004). Their different subcellular localization suggest specific 
biological roles for these enzymes wich are still to be defined. 
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Fig. 5: Covalent and non-covalent modification of a protein acceptor by PARP1. DNA BD: 
DNA binding domain; CD: Catalytic Domain; ADM; Automodification Domain (adapted from Zardo et al., 
2003). 
 
 
The best known is PARP1 which is responsible for about 90 % of all the ADP-ribose 
polymers found in cells (D’Amours et al., 1999). This enzyme is ubiquitously expressed 
although at tissue and cell-type specific level. PARP1 is involved in many physiological and 
pathological processes. The physiological roles of this enzyme include apoptosis, 
transcription, maintenance of  genomic stability, DNA-base excission repair and aging while 
in pathological conditions, an important role has been attributed to PARPs’ inhibitors in the 
cure of diabetes mellitus, ischaemia-reperfusion damage in heart, brain, kidney and bowel, 
acute and chronic inflammatory disorders and septic and haemorrhagic shock (Smulson et al., 
2000; Burkle, 2001). An increased catalytic activity by about 500 times is observed following 
nicks in both single and double strand DNA. Three domains, having three different functional 
roles, are present on the enzyme (Fig. 5). 
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The N-terminal domain, which contains zinc-finger motifs, recognizes nicks and 
successively links damaged DNA independently of the sequences involved (Ménissier-de 
Murcia et al., 1989). The central domain is termed automodification domain. There are 28 
sites of modification on it and it is on them that ADP-ribose polymers are built until long and 
branched chains are formed (Desmarais et al., 1991). The C-terminal tail contains the 
catalytic domain. The mechanism by which PARP1 modifies itself is particular. Around 
nicked DNA the enzyme works in dimeric form, and it is the catalytic site of one enzymatic 
molecule which introduces ADP-ribose units onto the central domain of the other one. This 
process is called automodification. Heteromodification occurs when ADP-ribose polymers are 
introduced onto different chromatin proteins. In vitro experiments suggest that automodified 
PARP1 or ADP-ribose polymers are by themselves able to interact with chromatin proteins 
also through uncovalent binding. The link is so strong that the association between protein 
and ADP-ribose polymers cannot be reversed either by drastic chemical conditions or by 
elevated concentration of single or double strand DNA vs polymers (Panzeter et al., 1992). 
Thus important chromatin proteins undergo covalent and uncovalent poly(ADP-ribosyl)ation 
(Fig. 5) and sometimes the same protein - see H1 histone (Panzeter et al., 1992, 1993) - is 
substrate for both modifications. Chromatin decondensation, induced by PARP activation was 
shown many years ago (Poirier et al., 1982). Recent research on Drosophila has demonstrated 
that active puff loci are rich in PARP1 and ADP-ribose polymers, this being the necessary 
condition  to induce chromatin decondensation and gene expression (Tulin and Spradling, 
2003). Mechanism of PARP1-mediated puffing and chromatin remodelling reinforces the idea 
previously suggested by Althaus to explain the role played by PARP1 in DNA repair 
(Althaus, 1992). 
 
Correlation between poly(ADP-ribosyl)ation and DNA methylation 
 
The Caiafa’s research group gave the evidence of a crosstalk between poly(ADP-ribosyl)ation 
and DNA methylation as they found that competitive inhibition of poly(ADP-ribose) 
polymerases (PARPs) leads to introduction of anomalous methyl groups onto DNA (Zardo et 
al., 1997; de Capoa et al., 1999; Zardo et al., 1999) and in particular onto some CpG islands 
(Zardo and Caiafa, 1998). To explain this phenomenon two possible molecular mechanisms 
have been proposed. The first one based on the observation that inhibition of PARP activity 
leads to over-expression of Dnmt1 in the anomalous G1/early S phase in vivo (Zardo et al., 
2002), thus allowing the premature formation of PCNA-Dnmt1 active complex in the phase in 
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which CpG islands undergo replication (Delgado et al., 1998). The second based on the 
observation that modified PARP1 and Dnmt1 coimmunoprecipitate in vivo and on data 
showing that ADP-ribose polymers, present on modified PARP1, almost completely inhibit 
Dnmt1 activity in vitro (Reale et al., 2005). Thus, inhibition of PARP activity could allow 
new methyl groups to be inserted onto DNA both during replication and in chromatin: during 
replication because inhibition of PARP activity induces Dnmt1 overexpression in G1/S phase 
and increases the formation of the active complex PCNA-Dnmt1 in this anomalous phase 
(Fig. 6, panel A) and in chromatin because unmodified PARP1 is unable to inhibit Dnmt1 
(Fig. 6, panel B). Although suggested mechanisms offer a possible explanation of how 
inhibition of PARP activity affects DNA methylation patterns, they need to be further 
investigated to make clear the connection between these two epigenetic modifications. 
Considering the great deal of research focused on the study of variation of Dnmt1 level in 
tumour cells, where an over-expression of Dnmt1 has often been seen as the cause of tumour 
suppressor gene hypermethylation and silencing, research has been focused on the previous 
finding showing that inhibition of PARP activity induces over-expression of Dnmt1.  
Data here reported show that expression and level of Dnmt1 are time-dependent on the 
treatment of cells with 3-aminobenzamide - a competitive inhibitor of PARP activity - so 
much so that short times of treatment induce an over-expression of Dnmt1 while longer times 
lead to its silencing. Investigation of a possible correlation between Dnmt1 level and DNA 
methylation pattern shows that the island that is present in the promoter of Dnmt1 loses its 
protection against methylation becoming silenced through methylation following inhibition of 
PARPs activity. The silencing of the enzyme goes with introduction of diffuse demethylation 
of those Alu sequences whose methylation is characteristic of normal cells. 
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Fig. 6 : Inhibition of PARP 
activity induces DNA 
hypermethylation. Panel A 
reports the scheme proposed to 
explain DNA hypermethylation 
dependent on PARP inhibition during 
DNA replication: (a) In normal cells, 
modified PARP1 plays a role in 
controlling the expression of Dnmt1 
in the appropriate cell-cycle phase, 
and thus the level of Dnmt1-PCNA 
active complex is low in G1/S phase. 
(b) Inhibition of PARP activity 
induces overexpression of Dnmt1 in 
G1/S phase, causing anomalously 
high level of the active Dnmt1-PCNA 
complex in this phase. Panel B 
reports the scheme proposed to 
explain DNA hypermethylation 
dependent on PARP inhibition in 
chromatin. (a) In normal cells, 
ADPR-polymers, present on PARP1, 
link in uncovalent way Dnmt1. 
Affinity of Dnmt1 for ADPR-
polymers is so high that they compete 
with dsDNA 30 times more 
concentrated for the binding with the 
enzyme and the presence of ADPR-
polymers almost completely inhibits 
the Dnmt1 activity in vitro.  (b), 
inhibition of poly(ADP-ribosyl)ation 
frees Dnmt1 from its tie with PARP1 
and in absence of ADPR-polymers 
Dnmt1 activity is restored. Thus, 
following inhibition of poly(ADP-
ribosyl)ation, the two mechanisms 
could cooperate in inducing 
anomalous DNA hypermethylation 
(adapted from Caiafa and Zampieri, 
2005). 
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Experimental procedures 
 
Cell culture and drug treatment of cells 
 
L929 mouse fibroblasts and human primary fibroblasts – from passage 19 to 32 - were 
maintained in Dulbecco’s modified Eagle’s medium (Cambrex) supplemented with 10 % fetal 
calf serum (Cambrex) at 37°C with 5% CO2. For 3-aminobenzamide (3-ABA) treatments 0,3 
– 0,5 x 106 cells were seeded in 10 cm Petri dishes and, after 24 hours, the culture medium 
was added of 3-ABA (Sigma) at a final concentration of 1 mM. The medium was replaced 
every 5 hours and the treatment was carried out up to 96 hours. Cell proliferation was 
monitored by counting viable cells (trypan blue exclusion) with a Burker chamber at each 
treatment time. For 5-aza-deoxycytidine (5-AZA) treatment, the growth medium was 
supplemented with 5 mM 5-AZA (Sigma) every 24 hours over 48 or 96 hours. Cells were then 
harversted by trypsinization, washed with PBS and eventually stored at -80°C for further 
analysis. 
 
SDS-PAGE and Western Blot 
 
To obtain nuclear lysates, fresh PBS-washed cell pellets were resuspended in ice-cold 
isolation buffer (10 mM TRIS-HCl pH 7.9, 4 mM MgCl2, 1 mM EDTA, 0.5 mM DTT, 0.25 
M Sucrose, 1% Triton X-100, 1 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml 
pepstatin) and incubated on-ice for 30 min. Nuclei were than harvested by 1000 x g 
centrifugation and lysed in ice cold lysis buffer (50 mM TRIS-HCl pH 7.8, 2 mM EDTA, 0.5 
M Nacl, 0.1 % NP-40, 1 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml 
pepstatin). To obtain total cell lysates PBS-washed cell pellets were resuspended in lysis 
buffer and incubated on-ice for 30 min. After sonication and high-speed centrifugation, both 
cellular and nuclear lysates, normalized for total protein content (50 – 100 mg) were resolved 
by 8% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes 
(Amersham Pharmacia Biotech) by electro-blotting. Western-blot analyses were performed 
according to standard procedures. Immunocomplexes were visualized by ECL-Plus 
chemiluminescent detection (Amersham Pharmacia Biotech) after reaction with the following 
primary antibodies: polyclonal antibody to human Dnmt1 (New England Biolabs), 
monoclonal antibody to mouse Dnmt1 (Imgenex), polyclonal antibody to Sp1 (H-225, Santa 
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Cruz), polyclonal antibody to Tubulin (E-19, Santa Cruz), monoclonal antibody to Poly(ADP-
ribose) (10H, Alexis). 
 
Quantitative and semi-quantitative RT-PCR 
 
Total RNA (1 mg), purified from human fibroblasts by RNeasy Mini Kit (Qiagen), was 
subjected to retrotrascription using Superscript First-Strand Synthesis system (Invitrogen). 
Real Time PCR reactions were carried out in a final volume of 25 ml of iQ SYBR Green 
Supermix (Bio-Rad), added of 150 nM specific primers and of an amount of cDNA 
corresponding to 10 ng of total RNA. To evaluate PCR efficiency for each couple of primers, 
a standard curve was generated using 1-fold serial dilutions (from 40 to 2,5 ng) of the cDNA 
control at 24 hours. Efficiency was in the range between 95 and 100%. The amount of Dnmt1 
cDNA was calculated from the standard curve and normalized with respect to that one of 18S 
rRNA. The following PCR primers (Ghoshal et al., 2005) were used for the analysis: Dnmt1, 
5'-AGGGAAAAGGGAAGGGCAAG-3’ sense, 5'-AGAAAACACATCCAGGGTCCG-3’ 
antisense and 18S rRNA, 5'-TCAAGAACGAAAGTCGGAGG-3’ sense, 5'-
GGACATCTAAGGGCATCACA-3’ antisense. PCR amplification was performed on a 
iCyclerIQ (Bio-Rad) thermal cycler adopting the following conditions: the initial denaturation 
at 95°C for 10 min; 45 cycles of: 95°C for 30 sec, 60°C for 30 sec, and 72°C for 30 sec. 
Dissociation at 95°C for 1 min and 55°C for 30 sec was performed to check for the formation 
of a primer dimer. The dissociation profile for the amplified products indicated that none of 
the primer pairs generated a dimer. For semi-quantitative RT-PCR analysis, PCR reactions 
were carried out in a final volume of 25 ml of PCR buffer (Invitrogen) added of 1.5 mM 
MgCl2, 0.2 mM dNTPs, 0.5 mM of the gene- specific primers, 1 U of Taq DNA polymerase 
(Invitrogen) and an amount of cDNA corresponding to 20 ng of total RNA. After denaturation 
at 94°C for 4 min, PCR was done for 32 cycles (Dnmt1), 35 (Dnmt3a and Dnmt3b) or 26 
cycles (Gus and b-Actin) of 45 sec at 94°C, 45 sec at the primer specific temperature of 
annealing and 1 min at 72°C followed by one step of 7 min at 72°C. Primer sequences and 
annealing temperatures were as follows: Dnmt1 (ac. num.: NM001379) 5’-
AGGAGGAGGAAGCTGCTA-3’ sense, 5’-CCACTCATACAGTGGTAGATTTG-3’ 
antisense, annealing temperature 53.7°C; Dnmt3a (ac. num.: NM022552) 5’-
TGGAAAGCGGTGACACGCC-3’ sense, 5’-CGCTTCTGCAGGGGCT-3’ antisense, 
annealing temperature 54,6°C; Dnmt3b (ac. num.: XM047018) 5’-
AGGATCTTTGGCTTTCCTGTGC-3’ sense, 5’-AATGAGCACCGTGTTAGGCTG-3’ 
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antisense, annealing temperature 57,7°C; (Gus (ac. num.: NM 000181) 5’-
GCGGCATTTTGTCGGCTGGGTGTG-3’ sense, 5’-
TGGCAGGGTGGTGGGGGTGAGTGTG-3’ antisense, annealing temperature 64°C; b-Actin 
(ac. num.: NM001101) 5’-CCCCGTGCTGCTGACCGAGGCC-3’ sense, 5’-
CCGCTCGGCCGTGGTGGTGAA-3’ antisense, annealing temperature 60°C. Amplification 
products were visualized by 2% agarose gel electrophoresis and ethidium bromide staining of 
the whole PCR reaction mix. 
 
Methylation-dependent restriction analysis 
 
Methylation-dependent restriction analysis of genomic DNA was performed as previously 
described (Zardo and Caiafa, 1998). Briefly, genomic DNAs were extracted by standard 
methods from human and mouse fibroblasts. DNA (1 mg) was subjected to digestion for 16 
hours at 37°C with 20 units of HpaII or MspI (New England Biolabs). The digested fragments 
(100 ng) were labelled by end-fill reaction in the presence of 0.5 U of polymerase I Klenow 
fragment (Invitrogen) and 10 mCi of [α-32P]dCTP (Amersham Pharmacia Biotech) in a 30 ml 
reaction volume for 15 min at room temperature. After ethanol precipitation of the reaction 
mix, the labelled DNA restriction fragments were evidenced by 2% agarose gel electophoresis 
followed by autoradiography of the gel. 
 
Methylation-sensitive Southern blot analysis 
 
The DNA methylation level of Alu Sx sequences was evaluated by Southern blot analysis. 
DNAs (2 mg) were digested with 40 U of MspI or HpaII for 16 hours at 37°C. After 1.5% 
agarose gel electrophoresis, the digested DNA was blotted on Hybond-N nylon membrane 
(Amersham-Pharmacia) and the presence of new-HpaII cutting sites was individuated by 
using two probes (Yandava et al., 1997) directed against Alu –Sx sequences: (Alu 1) 5’-
CGACCTCGAGATCTCGGCTCACTGCAA-3’ and (Alu 2) 5’-
CGACCTCGAGATCTCGGCTCACTGCAA-3’. Labelling of probes and detection was 
performed using DIG Oligonucleotide 3'-End Labeling Kit and DIG Luminescent Detection 
Kit (Roche).  
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Sodium bisulphite reaction 
 
Sodium bisulphite modification of genomic DNA was performed as previously described 
(Zardo and Caiafa, 1998) with minimal modifications. Briefly, genomic DNAs were extracted 
by standard methods from human fibroblasts both untreated and treated with 3-ABA. DNA (1 
mg) was denatured by adding NaOH to a final concentration of 0.3 M for 15 min at 37°C. For 
the sulphonation reaction, the DNAs were incubated in the dark for 17 hours at 55°C in the 
presence of 3.1 M sodium bisulphite, 0.5 mM hydroquinone and 6.25 M urea in a final 
volume of 0.24 ml at pH 5.0. DNAs were then purified from the mixture reactions using the 
Wizard DNA Clean-Up system (Promega) and resuspended in 50 ml of water. Alkaline 
desulphonation of DNA was performed at 37°C for 15 min by the addition of NaOH to the 
final concentration of 0.3 M. This solution was neutralized by adding ammonium acetate (pH 
7.0) to a final concentration of 3.0 M. After ethanol precipitation, the modified DNAs were 
dissolved in 20 ml of water and stored at -80°C. 
 
Methylation-sensitive PCR 
 
PCR amplification was carried out on 100 ng of bisulphite modified DNA in 25 ml of PCR 
buffer (Invitrogen) added of 1.5 mM MgCl2, 0.2 mM dNTPs, 0.5 mM of specific methylated 
(M: 5’-CGTCGTTTTCGTTTATCGTT-3’ sense, 5’-ATACCTACCGCCTACGAACA-3’ 
antisense) or unmethylated (U: 5’-GTTTTATTTTTTTGTATAGGGTATTG-3’ sense, 5’-
CCCCCATAATACCTACCACCT-3’ antisense) primer pairs and 0.6 U of Taq DNA 
polymerase (Invitrogen). Cycling conditions were as follows: 94°C for 4 min followed by 50 
cycles of 45 sec at 94°C, 60°C (reduced of 0.2°C after each cycle) for 30 sec, 72°C for 30 sec 
and a final extention of 10 min at 72°C. The amplification products were visualized by 2% 
agarose gel electrophoresis and ethidium bromide staining. Primer pairs were designed using 
MethPrimer software on Dnmt1 5’ full lenght GpG island (accessed on line at 
www.urogene.org/methprimer/index1.html). 
 
Genomic bisulphite sequencing 
 
Genomic sequencing analysis of the human Dnmt1 promoter region spanning from -152 to 
+85 was performed on bisulphite modified DNA (100 ng) from human fibroblasts. The 
bisulphite modified promoter of Dnmt1 was amplified using the following primers: 5’-
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TGGAATTGAGGATTTTATTTAAGG-3’ sense and 5’-
ATACCCTATACAAAAAAATAAAAC-3’antisense. The amplified DNAs were cloned into 
the TA-cloning vector (Invitrogen). Six independent clones for each sample were submitted to 
sequencing procedure (MWG-Biotech). Primer pairs for sequencing were designed using 
MethPrimer software. 
 
Description of myc-PARG construct 
 
Human PARG cDNA, containing the complete coding region, was isolated by PCR 
amplification using as template cDNA prepared from poly A+ selected RNA from human 
adult skeletal muscle. The following oligonucleotides were used in the PCR reaction: 5’-
CCGGAATTCAATGAATGCGGGCCCCGGCTGTGAACCC-3’ sense, -5’-
GCCGCTCGAGTCAGGTCCCTGTCCTTTGCCCTGAATG-3’ antisense. The amplified 
DNA fragment was cloned in the myc-tag expression vector pCS2-MT and sequenced by 
GeneLab Service (Enea-Casaccia). 
 
Cell transfections 
 
L929 mouse fibroblasts were transfected (using lipofectamine reagent) with either myc-vector 
empty or myc–PARG construct, together with pBabe Puro vector in a ratio 1:10. After 24 
hours cells were incubated for further 72 hours in culture medium supplemented with 
puromycin (4mg/ml). Cells were then rinsed twice with PBS and lysed and subjected to SDS-
PAGE and Western Blotting. 
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Results 
 
Effect of PARP activity inhibition on Dnmt1 expression 
 
In order to verify whether and how the level and the expression of Dnmt1 are dependent on 
poly(ADP-ribosyl)ation, inhibition of PARP activity was performed in parallel on mouse 
(Fig. 11 b and c) and human fibroblasts (Fig. 7) by using 1 mM 3-ABA, the competitive 
inhibitor of PARP activity and extending the time of treatment with the inhibitor up to 96 
hours.  
Experiments of Western Blot, carried out in human primary fibroblasts (Fig. 7a and b) 
show that Dnmt1 protein level increases three-fold vs control at early times of treatment with 
3-ABA, confirming what had already been seen in mouse cells blocked at different cell-cycle 
phases (Zardo et al., 2002). Unexpectedly, upon prolonged 3-ABA treatment, a sharp 
decrease of the protein can be observed. RT-PCR and Real-Time RT-PCR experiments show 
that the transitory induction of Dnmt1 level, followed by its remarkable decrease, depends on 
the modulation of Dnmt1 gene transcription (Fig. 7c and d).  
Proliferation of cell cultures was controlled at different treatment times (up to 96 hours) 
both for human and mouse fibroblasts. The curves were superimposable thus excluding 
differences in growth rates between control and treated cells (Fig. 8). 
 
Analysis of the methylation status of CpG islands and of Alu Sx sequences 
 
HpaII digestion of genomic DNA (Bird et al., 1985) was used to investigate a possible 
correlation between Dnmt1 level and the DNA methylation pattern. The diminishing of 
radioactive incorporation after digestion of genomic DNA with HpaII (Fig. 9 a and b), the 
restriction enzyme capable of cutting exclusively CCGG unmethylated sequences, was used 
to evaluate the anomalous insertion of new methyl groups onto CpG island regions. As 
control for the amount of DNA loaded in the restriction reactions, a parallel analysis was 
performed using MspI, the methylation unsensitive isoschizomer of HpaII. Tiny-fragments 
(100-300 bp), produced following digestion with HpaII of genomic DNA purified from 
control cells, were quantified by densitometric analysis and their amount considered as 1.0. 
Fig. 9 c and d shows that the amount of tiny fragments decreases progressively until 72 hours 
of treatment reaching the values of 0.31 and 0.19 respectively in mouse and human 
fibroblasts, while it is possible to observe an inversion of the phenomenon at 96 hours of  
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Fig. 7: Effect of PARP activity inhibition on Dnmt1 expression. Nuclear lysates from untreated 
(Ct) and treated (+ 3-ABA) human fibroblasts were analysed by SDS-PAGE and Western blotting with 
antibodies specific for Dnmt1 and for Sp1, (a). For each sample, the level of Dnmt1 protein was quantified by 
the densitometry of the band, which was normalized considering the internal level of Sp1. Dnmt1 levels are 
represented respect to the level of the untreated samples taken as 1.0, (b). RNAs, isolated from untreated (Ct) 
and treated (+ 3-ABA) human fibroblasts, were used to perform semi-quantitative RT-PCR in order to evaluate 
the mRNA levels of Dnmt1 using b-Actin and b-glucuronidase (Gus) as internal controls. (W) refers to the 
amplification performed in absence of template DNA (c). Dnmt1 mRNA level relative to 18 S rRNA level has 
been further assessed by Real-Time PCR and results are displayed (d) as fold of expression relative to the level 
measured for Dnmt1 mRNA in the untreated sample at 24 hours (Ct 24) taken as 1.0. 
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Fig. 8: Effect of 3-ABA treatment on proliferation of cultures. Cell proliferation was evaluated 
at each treatment time for untreated (Ct) and treated (ABA) human (a) and mouse fibroblasts (b) by counting 
viable cells after trypan blue staining. Counts are expressed as the total number of cells x 104 in a 10 cm Perti 
culture plate. The graphics are an average of three independent experiments. 
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Fig. 9: Analysis of the 
methylation status of 
CpG islands and of Alu 
Sx sequences. Detection of 
anomalous methyl groups on 
HpaII CpG island fragments by 
methylation-dependent 
restriction analysis was 
performed on genomic DNAs 
purified from cells treated with 
1 mM 3-ABA (+3-ABA) for 
24, 48, 72 and 96 hours vs 
DNAs purified from control 
cells (Ct). DNA samples from 
human fibroblasts (a) and from 
mouse fibroblasts (b) were 
digested with HpaII and with 
MspI and the obtained 
fragments were labelled by 
end-fill reaction. The 
autoradiographyc signal of the 
labelled fragments ranging 
from 100 to 300 bp, was 
quantified by desitometric 
analysis. Histograms for human 
(c) and mouse (d) fibroblasts 
show the amount of HpaII tiny 
fragments vs MspI fragments 
for each sample. The relative 
amount of digested fragments 
from untreated samples was 
taken as 1.0. The methylation 
status of Alu Sx repeated 
sequences was investigated by 
Southern blot (e) on DNAs 
purified from human fibroblasts both untreated (Ct) and treated for 96 hours in the presence of 3-ABA (+3-
ABA). DNA samples were digested with the methyl-sensitive enzyme HpaII (H) and its insensitive isoschizomer 
MspI (M, control for the amount of DNA). The presence of new HpaII cutting sites were visualized using two 
probes directed against two different Alu-Sx sequences (Alu1 and 2). As positive control for DNA 
demethylation, digestion was performed in parallel on DNA from cells treated for 48 and 96 hours with 5-AZA. 
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treatment. In fact, at this latter time the values are respectively 0.56 and 0.30. What we detect 
after shorter times of treatment confirms our previous data (Zardo and Caiafa, 1998) and the 
the lower quantity of inhibitor used during the cell treatment likely explains the need for 
longer times to see the decrease of tiny fragment level. The recovery of HpaII tiny fragments 
observed at 96 hours is a novel finding of great interest because it reveals an unexpected 
demethylation event. 
As further confirmation for demethylation, Southern-Blot analyses were carried out using 
two different probes against Alu Sx elements (Yandava et al., 1997) since these are enriched 
in CpG dinucleotides. Southern-blotting was carried out on DNAs purified from cells treated 
and untreated for 96 hours with 3-ABA after digestion of both samples with HpaII. Fig. 9e 
shows that DNA purified from 3-ABA treated cells has undergone increased digestion by 
HpaII due to the presence of new demethylated cutting sites within the Alu sequences. The 
pattern observed was similar to the one observed after treatment of cells with 5 mM 5-aza-
deoxycytidine (5-AZA) for 96 hours. 
 
Effect of PARP activity inhibition on the methylation pattern of the CpG island located 
in 5’ regulatory region of human Dnmt1 
 
DNA demethylation (Bird, 2003) may depend on either an active process, played by a DNA 
demethylating enzyme that could intervene as consequence of the spreading of anomalous 
methylation on DNA, or on a passive process in which Dnmt1, the enzyme able to guarantee 
the correct maintenance DNA methylation, is silenced. Considering the above mentioned 
results, one molecular mechanism that could explain the silencing of Dnmt1 is the alteration 
of the methylation pattern of its promoter after inhibition of PARP activity. To verify such 
hypothesis the methylation pattern of the CpG island located at Dnmt1 5’ region (Fig. 10 a) 
was analysed by bisulphite reaction (Frommer et al., 1992). As preliminary approach 
methylation-sensitive PCR (MSP) was performed on the first exon of Dnmt1 human gene. 
The region to examine was selected according to “MethPrimer” software evaluation. MSP 
detects a partial methylation of the chosen sequences since both methylated and unmethylated 
specific primers give a PCR product when DNA was purified from cells treated for 96 hours 
with 3-ABA (Fig. 10 b). The sequencing of a DNA promoter region was selected as further 
investigation to analyze its methylation state. As shown in Fig. 10 c, all twelve CpG 
dinucleotides present in the fragment are almost fully methylated unlike respective controls, 
where they are completely unmethylated. 
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Fig. 10: Effect of PARP 
activity inhibition on 
the methylation pattern 
of the CpG island 
located in 5’ regulatory 
region of human 
Dnmt1. Graphycal 
representation (a) of the CpG 
island region (dark gray line) 
colocalizing with the 
transcription start site (TS) of 
Dnmt1 (“CpG Island 
Searcher”, on-line at 
http://cpgislands.usc.edu/) and 
GpG (dashes) distribution 
within the 5’ region of human 
Dnmt1 gene. Genomic DNAs 
were extracted from human 
fibroblasts both untreated (Ct) 
and treated for 96 hours with 
3-ABA (+3-ABA), and 
bisulphite reaction was 
performed to obtain a 
methylation specific 
modification of the DNA 
sequence. (b) The methylation status of CpG dinucleotides within Dnmt1 promoter was assayed by methylation-
sensitive PCR analysis (MSP). Amplification was carried out adopting methylation (MF and MR) or 
unmethylation (UF and UR) specific primer pairs. MSP analyses of DNA purified from untreated cells (Ct) and 
the same DNA sample methylaled with bacterial Sss1 in-vitro (Ct m) were taken respectively as negative and 
positive controls of methylation. (W) refers to amplification performed in absence of template DNA. The 
amplification products were visualized by 2% agarose gel electrophoresis and ethidium bromide staining. 
The methylation status of Dnmt1 promoter region spanning from -152 to +85 (a) was further evaluated by 
bisulphite sequencing (c) following 3-ABA treatment. Six independent clones for each sample were analysed by 
sequencing procedure. Each row of circles represents the sequence of an individual clone. Open circle, 
unmethylated CpG site; filled circle, the methylated one. 
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Therefore, a deregulation of PARP activity allows the introduction of anomalous methyl 
groups on the CpG island present on Dnmt1 promoter. 
 
Dnmt1 silencing depends on both PARG over-expression and PARP activity inhibition 
in mouse fibroblast cells 
 
Experiments of poly (ADP-ribose) glycohydrolase (PARG) over-expression - the enzyme 
responsible for dynamic ADP-ribose polymer degradation in nuclei (D’Amours et al., 1999) – 
were performed on mouse cells to evaluate a direct involvement of ADP-ribose polymers in 
the regulation of Dnmt1 expression excluding secondary effects due to treatment of cells with 
3-ABA.  
Fig. 11 a shows that over-expression of this enzyme causes a sharp degradation of ADP-
ribose polymers associated with a remarkable reduction of Dnmt1 protein level. This result is 
in agreement with the decrease of Dnmt1 observed in mouse cells treated for prolonged times 
with 3-ABA (Fig. 11 b and c) and suggests that ADP-ribose polymers are involved in the 
control of Dnmt1 expression. 
 
PARP activity inhibition does not affect the mRNA level of other de novo DNA 
methyltrasferases 
 
An mRNA level time course of the known members of the DNA methyltrasferase enzyme 
family (Dnmt1, Dnmt3a and Dnmt3b) was performed following inhibition of poly(ADP-
ribosyl)ation in human fibroblasts by semi-quantitative RT-PCR. As shown in fig. 12, 3-ABA 
treatment of cells does not affect Dnmt3a and 3b mRNA levels, which remain comparable to 
untreated controls at each treatment time, while an initial induction followed by down-
regulation is detectable as already shown for Dnmt1 mRNA level. 
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Fig. 11: Dnmt1 silencing depends on both PARG over-expression and PARP activity 
inhibition in mouse fibroblast cells.  
Whole-cell extracts of L929 cells trasfected with myc-vector and myc-PARG analysed by Western blotting after 
3-days selection in puromycin. The blot was incubated with antibodies specific for poly(ADP-ribose) (PAR), 
myc, Dnmt1 and a-tubulin (a). Nuclear lysates from untreated L929 cells (Ct) and from the treated ones (+ 3-
ABA) were analysed by SDS-PAGE and Western blotting with antibodies specific for Dnmt1 and for Sp1, (b). 
For each sample, the level of Dnmt1 protein was quantified by the densitometry of the band, which was 
normalized considering the internal level of Sp1. Dnmt1 levels are represented respect to the level of the 
untreated samples taken as 1.0, (c). 
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Fig. 12: Effect of PARP activity inhibition on mRNA levels of the most important DNA 
methyltransferases. 
RNAs isolated from untreated (Ct) and treated (+ 3-ABA) human fibroblasts were used to perform semi-
quantitative RT-PCR in order to evaluate the mRNA levels of Dnmt1, Dnmt3a, Dnmt3b using b-actin and b-
glucuronidase (Gus) as internal controls. (W) refers to the amplification performed in absence of template DNA. 
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Discussion 
 
In conclusion these results confirm that by reducing PARP activity (after 24-48 hours of 
treatment with 3-ABA) there is a threefold increase in Dnmt1 level (Zardo et al., 2002) and 
modification of the genomic methylation pattern (Zardo et al., 1997; de Capoa et al., 1999; 
Zardo et al., 1999; Zardo and Caiafa, 1998). Additional data also indicate that, following 
inhibition of PARP activity, the promoter of Dnmt1 is no longer protected from anomalous 
methylation. 
These novel findings suggest a complex pathway focused on Dnmt1 in which the 
decreased activity of PARPs leads, in turn, to induction of Dnmt1 expression, to insertion of 
anomalous methyl groups onto CpG island located in the promoter region of Dnmt1 and to its 
transcriptional silencing that seems, therefore, to be responsible for a diffuse hypomethylation 
of genomic DNA.  
To have identified a CpG island protected from aberrant de novo methylation by 
poly(ADP-ribosyl)ation gives us the chance to put forward a mechanism by which PARP 
activity takes part in the protection of CpG islands. As has been said in the introduction, 
several models of mechanism(s) by which CpG islands are protected from the action of DNA 
methytransferases have been greatly debated. DNA methylation has the propensity to spread 
from methylated sites to adjacent unmethylated ones unless “boundary elements” are present 
(Turker, 2002). It has been suggested that a static barrier, protecting GpG islands from 
methylation, could be formed by transcription factors that could compete with Dnmts for sites 
within the CpG island preventing their methylation. This barrier action of trascription factors 
would be partially overcome by abnormal high levels of Dnmts (Vertino et al., 1996). 
Considering the inhibitory effect played by ADP-ribose polymers on Dnmt1 activity, the high 
affinity of this enzyme for ADP-ribose polymers and the existence in vivo of a complex 
between poly(ADP-ribosyl)ated PARP1 and Dnmt1 (Reale et al., 2005), a poly(ADP-
ribosyl)ated structural protein, or a transcription factor or an automodified member of the 
PARP family could be the element able to inhibit the Dnmt1 activity and block Dnmt1 access 
to CpG islands. Thus, following inhibition of poly(ADP-ribosyl)ation Dnmt1 loses its 
inhibitory tie with ADP-ribose polymers and gains access to unmethylated CpG dinucleotides 
(fig. 13). There is a growing list of DNA binding protein acceptors of poly(ADP-ribose) 
(D’amours et al., 1999) and the evaluation of the occupancy of Dnmt1 promoter by a 
poly(ADP-ribosyl)ated isoform of such a protein could be a favorable approach to the  
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Fig. 13: Mechanism suggested for the ADP-ribose-mediated protection of the 
unmethylated status of the CpG island located in Dnmt1 promoter region. In normal cells 
a poly(ADP-ribosyl)ated transcription factor (TF) bound to the CpG island located on the Dnmt1 promoter, 
links in a non covalent way Dnmt1 thus preventing its access GpG dinucleotides. In fact, Dnmt1is attracted 
to them rather than to DNA. Following this binding the catalytic activity of Dnmt1 is inhibited (Reale et al., 
2005). Decrease of ADP-ribose polymers (PAR) both by treatment of cells with inhibitors of PARP activity 
and by over-expression of PARG allows the introduction of new methyl groups onto the CpG island since 
low level of PAR de-represses Dnmt1 catalytic activity. 
 
understanding of the mechanism(s) by which ADP-ribose polymers mediate the protection 
of CpG islands. 
Data here reported demonstrate that the decrease of ADP-ribose polymers leads to a 
deregulation of the genome-wide methylation pattern suggesting that both hypermethylation 
of CpG islands and widespread hypomethylation could depend on poly(ADP-ribosyl)ation. 
This has a particular relevance considering that hypermethylation of CpG island promoter 
regions of tumour suppressor genes (Costello et al., 2000; Robertson, 2002; Jones and Baylin, 
2002; Baylin and Ohm, 2006) and widespread DNA hypomethylation (Hoffmann and Schulz, 
2005) are a relevant epigenetic event occurring in cancer (Fig. 14). Moreover, a great amount 
of research has been carried out over the years to see if the nuclear level of Dnmt1 is by itself 
capable of causing the aberrant methylation pattern in tumour cells (Vertino et al., 1996;  
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Fig. 14: DNA methylation and cancer. Graphical display of a representative region of genomic DNA in a 
normal cell and tumour cells where repeat-rich heterochromatin becomes hypomethylated and this contributes to 
genomic instability, through increased mitotic recombination events. De novo methylation of CpG islands also 
occurs in cancer cells, and this can result in the transcriptional silencing of some tumor suppressor genes (TSG). 
 
 
Baylin, 1997; Eads et al., 1999; Feltus et al., 2003; Rhee et al., 2000; Rhee et al., 2002; Leu 
et al.,2003; Robert et al., 2003; Ting et al., 2004¸ Suzuki et al., 2004) and in cells where 
Dnmt1 was stably over-expressed (Vertino et al., 1996) it has been possible to observe 
anomalous methylation of some tumour-suppressor genes. Subsequent research, carried out 
on the same cells, has shown that not all the CpG islands undergo methylation but only a few 
are prone to methylation when Dnmt1 was over-expressed (Feltus et al., 2003). The silencing  
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Fig. 15: Levels of Dnmt1 control DNA methylation pattern of genome 
 
 
of Dnmt1 by RNA interference has often been performed to establish if it leads to 
demethylation and re-expression of oncosuppressor genes in tumor cells (Leu et al.,2003; 
Robert et al., 2003; Ting et al., 2004; Suzuki et al., 2004). Of great interest are findings 
showing that Dnmt1 silencing allows also demethylation and re-expression of some germ-line 
specific genes whose repression is methylation-dependent in somatic cells (Loriot et al., 2006; 
Fang et al., 2006). As the promoters of these genes become demethylated in many tumour 
cells, this observation open up the possibility that a passive demethylation, due to silencing of 
Dnmt1, is involved in determining diffuse genome-wide hypomethylation . Of great interest is 
the recent finding that demethylation of sub-telomere CpG rich regions in Dnmt1-depleted 
cells lead to telomeres elongation (Gonzalo et al., 2006) (Fig. 15) 
In this context the silencing of Dnmt1 dependent on inhibition of PARP activity could 
represent a new experimental approach for the understanding of the role played by Dnmt1 in 
determining the aberrant methylation patterns in tumour cells. What is remarkable is that the 
demethylated pattern found in Alu sequences after treatment of cells with 3-ABA for 96 hours 
De novo methylation of CpG island sequences in human 
fibroblasts overexpressing DNA (cytosine-5)-methyltransferase 
Vertino P. et al. Mol. Cell. Biol. 1996; 16: 4555-65  
Increased cytosine DNA methyltransferase activity during 
colon cancer progression 
Issa, J., P. et al. J. Natl Cancer Inst. 1993; 85: 1235-40 
Abnormal regulation of DNA methyltranferase expression 
during colorectal carcinogenesis 
De Marzo, A., M. et al. Cancer Res. 1999; 59:3855-60 
Dnmt1 is required to maintain CpG methylation and aberrant 
gene silencing in human cancer cells 
Robert,  M., F. et al. Nat. Gen. 2003; 33: 61-65  
RNA interference-mediated knockdown of DNA 
methyltransferase 1 leads to promoter demethylation and  
gene re-expression in human lung and breast cancer 
Suzuki,  M. et al. Cancer Res. 2004; 64: 3137-3143 
Dnmt1 overexpression 
leads to CpG island 
methylation 
Loss of Dnmt1 causes 
demethylation  
 
DNA methyltransferases control  the telomere lenght and 
telomere recombination in mammalian cells 
Gonzalo,  S. et al. Nat. Cell. Biol. 2006; 4: 416-24  
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is very similar to the one found on DNA from cells treated with 5-AZA for the same time. 
The discovery of a DNA demethylating activity dependent on the use of inhibitors of 
poly(ADP-ribosyl)ation process increases the knowledge of mechanism by which these 
inhibitors enhance the cytotoxicity of other anticancer agents (Jagtap and Szabo, 2005). 
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